Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of date. This is page number 20.

Order by Relevance | Date

Total 2143 results found since Jan 2013.

Advances in immunotherapy for cervical cancer
Ther Adv Med Oncol. 2023 Mar 28;15:17588359231163836. doi: 10.1177/17588359231163836. eCollection 2023.ABSTRACTCervical cancer still represents a major public health problem, being the fourth most common cancer in incidence and mortality in women worldwide. These figures are unacceptable since cervical cancer, an human papillomavirus-related malignancy, is a largely preventable disease by means of well-established screening and vaccination programs. Patients with recurrent, persistent, or metastatic disease unsuitable for curative therapeutic approaches represent a dismal prognosis population. Until recently, these patient...
Source: Adv Data - April 3, 2023 Category: Epidemiology Authors: Juan Francisco Grau-Bejar Carmen Garcia-Duran David Garcia-Illescas Oriol Mirallas Ana Oaknin Source Type: research

Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis
Conclusion HPV vaccine communication is critical in ensuring that the community understands the importance of vaccination. The most effective communication strategies included those which educate the population about the HPV vaccine, facilitate decision-making on vaccine uptake and community ownership of the vaccination process immunisation. PROSPERO registration number CRD42021243683.
Source: BMJ Open - April 3, 2023 Category: General Medicine Authors: Oketch, S. Y., Ochomo, E. O., Orwa, J. A., Mayieka, L. M., Abdullahi, L. H. Tags: Open access, Communication Source Type: research

Are Interventions Efficacious at Increasing Human Papillomavirus Vaccinations Among Adults? A Meta-Analysis
CONCLUSION: Evidence supports the efficacy of interventions to increase intentions to receive the HPV vaccine and completion of the HPV vaccine series in adults. However, evidence did not support the efficacy of interventions to increase HPV vaccine initiation. Findings highlight directions for developing more efficacious HPV vaccine interventions for adults.PMID:37001049 | DOI:10.1093/abm/kaac043
Source: Annals of Behavioral Medicine - March 31, 2023 Category: Psychiatry & Psychology Authors: Sara E Fleszar-Pavlovi ć Linda D Cameron Source Type: research

Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV
Int J Mol Sci. 2023 Mar 15;24(6):5642. doi: 10.3390/ijms24065642.ABSTRACTTo determine the value of low-risk human papillomavirus (HPV) PCR to screen for "high-grade anal squamous intraepithelial lesion and anal cancer" (HSIL-plus), rate of patients with low-grade anal squamous intraepithelial lesion (LSIL) progressing to HSIL-plus, and progression-related factors. Prospective, longitudinal study of consecutive MSM-LHIV attended between May 2010 and December 2021 and followed for 43 months (IQR: 12-76). HIV-related variables were gathered at baseline, performing anal cytology for HPV detection/genotyping, thin-layer cytolog...
Source: Anal Sci - March 29, 2023 Category: Chemistry Authors: Carmen Mar ía García-Martínez Inmaculada Calle-G ómez Javier L ópez-Hidalgo Patricia G ómez-Ronquillo Mohamed Omar-Mohamed Balgahata Carmen Hidalgo-Tenorio Source Type: research

Latino Adolescent-Mother Language Concordance, Neighborhood Deprivation, and Vaccinations in Community Health Centers
Conclusions: In a multistate analysis of vaccinations among Latino and non-Latino adolescents, English-preferring adolescents with Spanish- preferring mothers had the highest completion rates and English-preferring non-Hispanic white dyads had the lowest. Further research can seek to understand why this language dyad may have an advantage in adolescent vaccination completion.PMID:36976843 | DOI:10.1370/afm.21.s1.3815
Source: Annals of Family Medicine - March 28, 2023 Category: Primary Care Authors: Rachel Springer John Heintzman Jorge Kaufmann Sophia Giebultowicz Miguel Marino Nathaniel Warren Heather Angier Source Type: research

Basic research on curcumin in cervical cancer: Progress and perspectives
Biomed Pharmacother. 2023 Mar 23;162:114590. doi: 10.1016/j.biopha.2023.114590. Online ahead of print.ABSTRACTCurcumin is a polyphenolic substance extracted from plants such as Curcuma longa, Curcuma zedoaria, and radix curcumae, and it has attracted much attention because of the anti-inflammatory, antioxidant, anti-tumor, antibacterial and other multiple pharmacological effects. Cervical cancer is one of the most common malignant tumors in women. With the application of HPV (human papillomavirus) vaccine, the incidence of cervical cancer is expected to be reduced, but it remains difficult to promote the vaccine among low-...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 25, 2023 Category: Drugs & Pharmacology Authors: Xiaoyu Zhang Lin Zhu Xuezhen Wang Hairong Zhang Lianzhong Wang Lei Xia Source Type: research

Precision and correlation of ED < sub > 50 < /sub > and endpoint titer method in measuring HPV vaccine immunogenicity
J Virol Methods. 2023 Mar 23:114716. doi: 10.1016/j.jviromet.2023.114716. Online ahead of print.ABSTRACTCervical cancer, the second leading cause of cancer-related deaths among women, is caused by human papillomavirus (HPV), a sexually transmitted virus. Vaccination is an effective preventive measure against viral infections and subsequent development of cervical cancer. Enzyme-linked immunosorbent assay (ELISA) is commonly used to measure specific binding antibody titers and assess the immunogenicity of test vaccines in preclinical models or clinical volunteers. Two methods of deriving titers, the endpoint titer (ET) and ...
Source: Journal of Virological Methods - March 25, 2023 Category: Virology Authors: Dekui Qiu Yue Liu Zhiping Wang Zhigang Zhang Meifeng Nie Ningshao Xia Shaowei Li Qinjian Zhao Source Type: research

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
CONCLUSIONS: By linking nation-wide registries on pathology and vaccination, we show significant beneficial early effects of HPV-vaccination on LSIL, HSIL+, CIN3/AIS/carcinoma and hrHPV detection in young women upto 24 years of age who have a cervical sample taken before entry into the cervical cancer screening program.PMID:36965085 | DOI:10.1002/cam4.5842
Source: Cancer Control - March 25, 2023 Category: Cancer & Oncology Authors: Tessa M Schurink-van 't Klooster Albert G Siebers Joske Hoes Folkert J van Kemenade Johannes Berkhof Johannes A Bogaards Hester E de Melker Source Type: research